All News

Pharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.

Consumption of sugary drinks regularly may be a major contributory factor to the epidemic of cancer, according to a study published by the British Medical Journal.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Treatment options include anti-inflammatory and anti-itch drugs, as well as medications that suppress the immune system.

A Message from American Pharmacists Association (APhA) President-elect, Dr. Sandra Leal.

The research team designed TETi76 to replicate and amplify the effects of a natural molecule called 2-hydroxyglutarate (2HG), which inhibits the enzymatic activity of TET genes.

PQA is a national quality organization that brings 250 organizations from across health care together to develop and implement quality measures, conduct research and provide education that supports better medication use and high-quality care.

Favipiravir tablets are indicated for the acute treatment of mild to moderate COVID-19 adult patients.

Glenmark's drug product is a generic equivalent to Eli Lilly’s Cialis Tablets.

Pfizer and BioNTech, and Moderna have announced agreements to further supply vaccines against the coronavirus disease 2019 (COVID-19).

According to AstraZeneca, the company is currently conducting a large trial in the US and in other countries around the world.

Having a sense of professional identity is important for longevity in the profession, prevention of burnout, ethical practice, and mentorship of others in the same field.

Amphastar Pharmaceuticals’ generic glucagon for injection USP, 1 mg/vial packaged in an emergency kit, is indicated for the treatment of severe hypoglycemia, which may occur in patients with diabetes mellitus.

Deferred care can result in worse outcomes, advanced complications, or earlier death for many patients with cancer, heart disease, and other serious illnesses.

Pharmacologic approaches should be considered primarily in patients who are unable to participate in cognitive behavioral therapy and those who still have symptoms after this therapy.

More and newer treatment options mean that patients will benefit from various regimens and strategies.

Pharmacy Times spoke with Jeremy Barnett, LMHC, CASAC & Expert at Help.org, about recommended plans and advice for those who are struggling with addiction during the holidays and the COVID-19 pandemic.

Pharmacy Times spoke with Jeremy Barnett, LMHC, CASAC & Expert at Help.org, about substance abuse dangers during COVID-19 and the holiday season.

Earlier this month, the Canadian government also exercised its option to increase its confirmed order commitment of mRNA-1273.

This agreement brings the total number to be delivered to the United States to 200 million.

In CNN's recent Sesame Street ABC's of COVID-19 town hall, Anthony Fauci, MD, answered questions addressing children’s concerns for Santa’s health during the COVID-19 pandemic.

Pharmacists must demonstrate value to achieve success when implementing new services and especially when establishing an entirely new practice.

Targeting screening to high-risk groups who are less compliant with recommendations could be more effective than general age-based recommendations.

The kit will be shipped overnight to the customer’s home, where they can self-administer the test collection using a short nasal swab and send their sample back to Labcorp.

Emphasizing the importance of the COVID-19 vaccine to younger generations and those with no underlying health conditions could significantly increase the overall rate of vaccination in the United States.

Anakinra was initially approved by FDA in November 2001 for treatment of moderate to severe active rheumatoid arthritis.

A new study indicates cheese is the most protective food against age-related cognitive problems.

The announcement came hours after the companies disclosed that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) had issued a positive opinion to authorize the vaccine.